This Funding Opportunity Announcement (FOA) will support applications aimed at:
(1) determining whether microbial pathogens represent a causal component ?of Alzheimers disease (AD), (2) establishing mechanisms by which microbial pathogens impact neurodegenerative processes in AD, and (3) informing
credit:
aspects of future translational studies in AD, including the discovery of candidate therapeutics aimed at regulating pathogen-associated networks and molecules in AD.